Literature DB >> 33488735

From TTP to Glomerulonephritis: A Lifetime of Lupus.

Fadi Kharouf1,2, Sigal Shahar1, Yoav Hershkovitz1, Alaa Shaheen1, Areej Bayatra1, Asa Kessler1, Yuval Ishay1,3.   

Abstract

We report the case of a 56-year-old male patient, who over two decades, sequentially presented with a combination of clinical manifestations. These included thrombotic thrombocytopenic purpura (TTP), right leg deep vein thrombosis (DVT), and eventually constitutional symptoms, arthralgia, diffuse lymphadenopathy, pancytopenia, skin rash, pericarditis, and glomerulonephritis. Serologic tests and renal pathology uncovered a diagnosis of systemic lupus erythematosus (SLE), and immunosuppressive therapy was initiated. Soon after, the patient developed striking cytomegalovirus (CMV) viremia, requiring prolonged antiviral therapy and reduction of immunosuppression. Finally, an acute embolic stroke complicated the disease course. Prompt interventions allowed an excellent clinical outcome.
Copyright © 2021 Fadi Kharouf et al.

Entities:  

Year:  2021        PMID: 33488735      PMCID: PMC7803419          DOI: 10.1155/2021/6654748

Source DB:  PubMed          Journal:  Case Rep Med


  20 in total

1.  Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus.

Authors:  M Kuwana; J Kaburaki; Y Okazaki; H Miyazaki; Y Ikeda
Journal:  Rheumatology (Oxford)       Date:  2006-01-17       Impact factor: 7.580

Review 2.  Fever of unknown origin: a clinical approach.

Authors:  Burke A Cunha; Olivier Lortholary; Cheston B Cunha
Journal:  Am J Med       Date:  2015-06-18       Impact factor: 4.965

Review 3.  CMV: Prevention, Diagnosis and Therapy.

Authors:  C N Kotton
Journal:  Am J Transplant       Date:  2013-02       Impact factor: 8.086

4.  An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus.

Authors:  C A Roldan; B K Shively; M H Crawford
Journal:  N Engl J Med       Date:  1996-11-07       Impact factor: 91.245

5.  Features associated with cardiac abnormalities in systemic lupus erythematosus.

Authors:  J Bourré-Tessier; T Huynh; A E Clarke; S Bernatsky; L Joseph; P Belisle; C A Pineau
Journal:  Lupus       Date:  2011-10-04       Impact factor: 2.911

Review 6.  Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.

Authors:  S Giannouli; M Voulgarelis; P D Ziakas; A G Tzioufas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

7.  Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996-2004.

Authors:  Michael M Ward
Journal:  J Rheumatol       Date:  2009-01       Impact factor: 4.666

Review 8.  Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies.

Authors:  Marie Holmqvist; Julia F Simard; Kjell Asplund; Elizabeth V Arkema
Journal:  RMD Open       Date:  2015-12-16

9.  Generalized Lymphadenopathy as Presenting Feature of Systemic Lupus Erythematosus: Case Report and Review of the Literature.

Authors:  Wais Afzal; Talal Arab; Tofura Ullah; Katerina Teller; Kaushik J Doshi
Journal:  J Clin Med Res       Date:  2016-09-29

Review 10.  Systemic lupus erythematosus: state of the art on clinical practice guidelines.

Authors:  Farah Tamirou; Laurent Arnaud; Rosaria Talarico; Carlo Alberto Scirè; Tobias Alexander; Zahir Amoura; Tadej Avcin; Alessandra Bortoluzzi; Ricard Cervera; Fabrizio Conti; Alain Cornet; Hervé Devilliers; Andrea Doria; Micol Frassi; Micaela Fredi; Marcello Govoni; Frederic Houssiau; Ana Lladò; Carla Macieira; Thierry Martin; Laura Massaro; Maria Francisca Moraes-Fontes; Cristina Pamfil; Sabrina Paolino; Chiara Tani; Sander W Tas; Maria Tektonidou; Angela Tincani; Ronald F Van Vollenhoven; Stefano Bombardieri; Gerd Burmester; Fonseca João Eurico; Ilaria Galetti; Eric Hachulla; Ulf Mueller-Ladner; Matthias Schneider; Vanessa Smith; Maurizio Cutolo; Marta Mosca; Nathalie Costedoat-Chalumeau
Journal:  RMD Open       Date:  2018-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.